Teva Introduces Budeprion XL® [Bupropion Hydrochloride Extended-Release Tablets USP (XL)], 150 mg

North Wales, Pennsylvania, May 30, 2008— Teva Pharmaceuticals is pleased to announce the introduction and availability of Budeprion XL® [Bupropion Hydrochloride Extended-Release Tablets USP (XL)], 150 mg. This product is AB rated and bioequivalent to Wellbutrin XL®* Tablets. With the addition of this new strength, Teva now offers Budeprion XL® Tablets in 150 mg and 300 mg strengths, in bottle sizes of 30 and 500.